Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia
- PMID: 7913883
- DOI: 10.1016/0092-8674(94)90302-6
Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia
Abstract
Achondroplasia (ACH) is the most common genetic form of dwarfism. This disorder is inherited as an autosomal dominant trait, although the majority of cases are sporadic. A gene for ACH was recently localized to 4p16.3 by linkage analyses. The ACH candidate region includes the gene encoding fibroblast growth factor receptor 3 (FGFR3), which was originally considered as a candidate for the Huntington's disease gene. DNA studies revealed point mutations in the FGFR3 gene in ACH heterozygotes and homozygotes. The mutation on 15 of the 16 ACH-affected chromosomes was the same, a G-->A transition, at nucleotide 1138 of the cDNA. The mutation on the only ACH-affected chromosome 4 without the G-->A transition at nucleotide 1138 had a G-->C transversion at this same position. Both mutations result in the substitution of an arginine residue for a glycine at position 380 of the mature protein, which is in the transmembrane domain of FGFR3.
Similar articles
-
Achondroplasia is defined by recurrent G380R mutations of FGFR3.Am J Hum Genet. 1995 Feb;56(2):368-73. Am J Hum Genet. 1995. PMID: 7847369 Free PMC article.
-
Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia.Horm Res. 1996;45(1-2):108-10. doi: 10.1159/000184768. Horm Res. 1996. PMID: 8742128 Review.
-
[Differentiation of achondroplasia and other similar genetic dwarfism by FGFR3 gene analysis].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2000 Aug;17(4):252-5. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2000. PMID: 10932008 Chinese.
-
Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene.Turk J Pediatr. 2003 Apr-Jun;45(2):99-101. Turk J Pediatr. 2003. PMID: 12921294
-
Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia--genetic short limbed dwarfism.Curr Drug Targets. 2003 Jul;4(5):353-65. doi: 10.2174/1389450033490993. Curr Drug Targets. 2003. PMID: 12816345 Review.
Cited by
-
International expert opinion on the considerations for combining vosoritide and limb surgery: a modified delphi study.Orphanet J Rare Dis. 2024 Sep 17;19(1):347. doi: 10.1186/s13023-024-03236-4. Orphanet J Rare Dis. 2024. PMID: 39289684 Free PMC article.
-
Review of patients with achondroplasia: a single-center's experience with follow-up and associated morbidities.Eur J Pediatr. 2024 Sep;183(9):3819-3829. doi: 10.1007/s00431-024-05643-y. Epub 2024 Jun 15. Eur J Pediatr. 2024. PMID: 38879704 Free PMC article.
-
Advances in the management of achondroplasia.Nat Rev Endocrinol. 2024 Aug;20(8):443-444. doi: 10.1038/s41574-024-00994-w. Nat Rev Endocrinol. 2024. PMID: 38740894 No abstract available.
-
Sleep-Disordered Breathing in an Infant With Achondroplasia and Foramen Magnum Stenosis.Cureus. 2024 Mar 16;16(3):e56291. doi: 10.7759/cureus.56291. eCollection 2024 Mar. Cureus. 2024. PMID: 38623108 Free PMC article.
-
Long-term oral meclozine administration improves survival rate and spinal canal stenosis during postnatal growth in a mouse model of achondroplasia in both sexes.JBMR Plus. 2024 Feb 24;8(4):ziae018. doi: 10.1093/jbmrpl/ziae018. eCollection 2024 Apr. JBMR Plus. 2024. PMID: 38544920 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
